REQUEST A DEMO
Total
USD $0.00
Search more companies

Global Pharma Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Global Pharma Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: November 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Global Pharma Ilac A.S. is an enterprise in Turkiye, with the main office in Istanbul. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was incorporated on March 25, 2011. It currently has a total number of 6 (2024) employees. There was a net sales revenue increase of 1.91% reported in Global Pharma Ilac A.S.’s latest financial highlights for 2021. There was a total growth of 2.59% in Global Pharma Ilac A.S.’s total assets over the same period. The net profit margin of Global Pharma Ilac A.S. increased by 52.95% in 2021.

Headquarters
Beybi Giz Plaza A Blok No:106 Maslak Mahallesi Maslak Meydan Sokak Sariyer
Istanbul; Marmara; Postal Code: 34485

Contact Details: Purchase the Global Pharma Ilac A.S. report to view the information.

Website: http://www.globalpharma.com.tr

Basic Information
Total Employees:
Purchase the Global Pharma Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Global Pharma Ilac A.S. report to view the information.
Incorporation Date:
March 25, 2011
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Global Pharma Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
1.91%
Total operating revenue
1.91%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
96%
Total assets
2.59%
Total equity
-6.11%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
52.95%
Return on Equity (ROE)
146.26%
Quick Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?